Skip to main content
. 2019 Nov 6;8(12):634–643. doi: 10.1089/wound.2018.0821

Table 1.

PARP-1 inhibitors in clinical development that may be repurposed for wound healing

PARP Inhibitor Target PARP
Talazoparib (BMN-673)—most potent PARP-1/2
Veliparib (ABT-888) PARP-1/2
Rucaparib (AG-014699. CO-338) PARP-1/2
Olaparib (AZD-2281) PARP-1/2/3
CEP-9722 PARP-1/2
Niraparib (MK-4827) PARP-1/2

PARP, polyadenosine diphosphate (ADP)-ribose polymerase.